Abstract
Gastric carcinoma is the fifth most common and the third leading cause of cancer deaths worldwide. The incidence of diffuse-type gastric cancer, of which signet ring cell carcinoma is a subtype, is rising in the world. Due to non-specific gastritis-like symptoms, difficulty in assessing true tumor characteristics owing to its horizontal spread, and non-distinguishable endoscopic appearance from other gastric pathologies, the diagnosis of this subtype is challenging. We present a case of a 67-year-old woman with progressively worsening abdominal pain who came for an endoscopic ultrasound evaluation of an incidentally noted pancreatic cyst on a previous MRI. During endoscopy, a 1-cm gastric ulcer was noted along the lesser curvature of the gastric body. Biopsy confirmed a diagnosis of gastric signet ring cell carcinoma (SRCC) with CDX-2 and keratin positivity. The patient underwent total gastrectomy with Roux-en-Y reconstruction. Gross specimen revealed a diffuse SRCC invading the muscularis propria, along with lymphovascular and perineural invasion. In the context of our case, we discuss the morphological features of SRCC and the effectiveness of treatment options based on existing literature. Early accurate diagnosis and staging play an important role in determining treatment options as well as the clinical course of gastric SRCC.
Similar content being viewed by others
References
Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C et al (2022) Gastric cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 20(2):167–92
Drubay V, Nuytens F, Renaud F, Adenis A, Eveno C, Piessen G (2022) Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World J Gastrointest Oncol 14(8):1406–1428
Johnston FM, Beckman M (2019) Updates on management of gastric cancer. Curr Oncol Rep 21(8):67
Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G et al (2022) Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):1005–1020
Shen J, Ma X, Yang J, Zhang JP (2019) Digestive tract reconstruction options after laparoscopic gastrectomy for gastric cancer. World J Gastrointest Oncol 12(1):21–36
Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T et al (2022) The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: a population-based modelling study. EClinicalMedicine 47:101404
Sexton RE, Hallak MN Al, Uddin MdH, Diab M, Azmi AS (2020) Gastric cancer heterogeneity and clinical outcomes. Technol Cancer Res Treat. 19:153303382093547
Zhang C, Liu R, Zhang WH, Chen XZ, Liu K, Yang K et al (2021) Difference between signet ring cell gastric cancers and non-signet ring cell gastric cancers: a systematic review and meta-analysis. Front Oncol 11:618477
Zaafouri H, Jouini R, Khedhiri N, Khanchel F, Cherif M, Mesbahi M et al (2022) Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country. World J Surg Oncol 20(1):238
Tang YH, Ren LL, Mao T (2023) Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: a literature review. World J Gastrointest Endosc 15(4):240–247
Pernot S (2015) Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol 21(40):11428
Xu Z, Jin Y, Fang X (2018) Advances in the research of gastric signet ring cell carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 21(10):1196–1200
Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64(1):31–49
Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S (2014) Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol 20(19):5679–5684
Zhao B, Lv W, Zhang J, Zhang J, Huang B, Lin J (2020) Different prognostic significance of signet ring cell histology for early and advanced gastric cancer patients: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 14(6):499–509
Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W, de Manzoni G (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22(1):1–9
Zhao X, Cai A, Xi H, Song Y, Wang Y, Li H et al (2017) Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology: a meta-analysis. ANZ J Surg 87(12):981–986
Kao YC, Fang WL, Wang RF, Li AFY, Yang MH, Wu CW et al (2019) Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer. Gastric Cancer 22(2):255–263
Wang Z, Zhang X, Hu J, Zeng W, Zhou Z (2015) Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology. J Visc Surg 152(6):357–361
Yao K, Anagnostopoulos G, Ragunath K (2009) Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 41(05):462–467
Phalanusitthepha C, Grimes KL, Ikeda H, Sato H, Sato C, Hokierti C et al (2015) Endoscopic features of early-stage signet-ring-cell carcinoma of the stomach. World J Gastrointest Endosc 7(7):741
Machlowska J, Pucułek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R (2019) State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res 11:2151–2161
Kang SH, Kim JS, Moon HS, Lee ES, Kim SH, Sung JK et al (2017) Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky? Medicine 96(33):e7532
Lee JH, Choi IJ, Kook MC, Nam BH, Kim YW, Ryu KW (2010) Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg 97(5):732–736
Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian gastrointestinal tumor study group. Ann Surg 230(2):170–8
Kim JH, Lee YC, Kim H, Song KH, Lee SK, Cheon JH et al (2009) Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc 69(4):e1-9
Bang CS, Park JM, Baik GH, Park JJ, Joo MK, Jang JY et al (2017) Therapeutic outcomes of endoscopic resection of early gastric cancer with undifferentiated-type histology: a Korean ESD Registry Database Analysis. Clin Endosc 50(6):569–577
Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G et al (2015) High-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas: what is the impact on perioperative and oncologic outcomes? Ann Surg Oncol 22(11):3632–3639
Heger U, Blank S, Wiecha C, Langer R, Weichert W, Lordick F et al (2014) Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Ann Surg Oncol 21(5):1739–1748
Kim S, Fiteni F, Paget-Bailly S, Ghiringhelli F, Lakkis Z, Jary M et al (2015) The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas. J Hematol Oncol 8(1):52
Chen L, Shi Y, Yuan J, Wu Q, Han Y, Qin R et al (2014) Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients. Med Oncol 31(9):159
Cunningham S, Kamangar F, Kim M, Hammoud S, Haque R, Maitra A et al (2005) Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 9(5):718–725
Lu M, Yang Z, Feng Q, Yu M, Zhang Y, Mao C et al (2016) The characteristics and prognostic value of signet ring cell histology in gastric cancer. Medicine 95(27):e4052
Lemoine N, Adenis A, Bouche O, Duhamel A, Heurgue A, Leteurtre E et al (2016) Signet ring cells and efficacy of first-line chemotherapy in advanced gastric or oesogastric junction adenocarcinoma. Anticancer Res 36(10):5543–5550
Pernot S, Mitry E, Samalin E, Dahan L, Dalban C, Ychou M et al (2014) Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. Gastric Cancer 17(2):341–347
Pernot S, Dubreuil O, Tougeron D, Soudan D, Bachet JB, Lepère C et al (2015) Docetaxel, 5FU, oxaliplatin (TEFOX) in 1st line treatment of signet ring cell and/or poorly differentiated gastric adenocarcinoma: a retrospective study of AGEO. J Clin Oncol 33(15_suppl):e15048
Turgeon MK, Gamboa AC, Rupji M, Lee RM, Switchenko JM, El-Rayes BF et al (2021) Should signet ring cell histology alter the treatment approach for clinical stage I gastric cancer? Ann Surg Oncol 28(1):97–105
Arer IM, Yabanoglu H, Akdur A, Akkapulu N, Kus M (2017) Total versus subtotal gastrectomy for signet ring cell carcinoma of the stomach. J Coll Physicians Surg Pak 27(10):616–620
Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM (2021) Partial gastrectomy is associated with improved overall survival in signet-ring cell gastric cancer. J Surg Res 266:27–34
Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J (2015) Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol 21(40):11428–11438
Xiong ZF, Shi J, Fu ZH, Wan HP, Tu LX (2017) Phenotypic classification of gastric signet ring cell carcinoma and its relationship with K-ras mutation. Genet Mol Res 16(2)
Masood MA, Loya A, Yusuf MA (2016) CDX2 as a prognostic marker in gastric cancer. Acta Gastroenterol Belg 79(2):197–200
Fisher SB, Fisher KE, Squires MH, Patel SH, Kooby DA, El-Rayes BF et al (2014) HER2 in resected gastric cancer: is there prognostic value? J Surg Oncol 109(2):61–66
Seo HM, Chang YS, Joo SH, Kim YW, Park YK, Hong SW et al (2009) Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol 99(3):143–147
Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A (2012) Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol 3(3):251–261
Zhang M, Zhu G, Zhang H, Gao H, Xue Y (2010) Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg 14(4):601–606
Kim JP, Kim SC, Yang HK (1994) Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 3(4):221–227
Ribeiro MM, Sarmento JA, Simões MAS, Bastos J (1981) Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer 47(4):780–784
Hass HG, Smith U, Jäger C, Schäffer M, Wellhäußer U, Hehr T et al (2011) Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren’s): single-center experience of 160 cases. Onkologie 34(12):682–6
Sakai T, Koshita S, Ito K, Kanno Y, Ogawa T, Kusunose H et al (2018) Signet-ring Cell Carcinoma derived from a main duct-type intraductal papillary mucinous neoplasm of the pancreas: a case report with long-term follow-up. Intern Med 57(8):1093–1099
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Montecino, R.M.B., Sukhorosl, M., Francis, M.A. et al. A Rare Case of Primary Gastric Signet Ring Cell Carcinoma: a Review of Guidelines for the Management of Gastric Cancer. Indian J Surg Oncol 15, 153–159 (2024). https://doi.org/10.1007/s13193-023-01852-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-023-01852-3